Author: News Room
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Stellantis To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Stellantis between February 15, 2024 and July 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 06, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Stellantis N.V. (“Stellantis” or…
Washington, DC, Sept. 06, 2024 (GLOBE NEWSWIRE) — AmeriCorps, the federal agency for national service and volunteerism, recognized four AmeriCorps members and two grantees in the State and National program for their excellence in service. Each year, AmeriCorps State and National recognizes programs and individuals for the Excellence in AmeriCorps Award that consistently supports its mission in the following categories: Impactful Service Award, Inclusive Service Award, Innovative Service Award and Lifetime of Service Award. “These remarkable individuals and programs exemplify the very best of what AmeriCorps stands for—dedication, innovation, and a deep commitment to service. Their work is not only…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In STMicroelectronics To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in STMicroelectronics between January 25, 2024 to July 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 06, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against STMicroelectronics N.V. (“STMicroelectronics” or the…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Starbucks To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Starbucks between November 2, 2023 and April 30, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 06, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Starbucks Corporation (“Starbucks” or…
Company’s industry-first technology addresses chronic low back painAclarion secured its first commercial agreement with Michigan’s Sheridan Community HospitalPRISM Emerging Medical Devices Index features companies at forefront of innovation and market disruption in medtech NEW YORK, Sept. 06, 2024 (GLOBE NEWSWIRE) — PRISM MarketView, a leading provider of market insights and company news, is excited to announce that Aclarion, Inc. (NASDAQ: ACON) has been added to the PRISM Emerging Medical Devices Index, which highlights companies at the forefront of innovation and market disruption in the medtech sector. Aclarion’s innovative AI-driven diagnostic solutions for chronic low back pain position the company as…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In DexCom To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in DexCom between January 8, 2024 to July 25, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 06, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against DexCom, Inc. (“DexCom” or…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In PDD To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in PDD between April 30, 2021 and June 25, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 06, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against PDD Holdings Inc. f/k/a…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Oddity To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 investing in Oddity stock or options between July 19, 2023 and May 20, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 06, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Super Micro Computer To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Super Micro Computer between February 2 2021 and August 28, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 06, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against…
Mount Laurel, NJ, Sept. 06, 2024 (GLOBE NEWSWIRE) — Pinnacle Treatment Centers (PTC), a national leader in integrated addiction treatment services, is pleased to announce the appointment of Chris Dennis, M.D. as Chief Medical Officer, and Carin Kottraba, Ph.D., as Chief Clinical Officer. Together, they bring over 40 years of distinguished experience to Pinnacle’s executive leadership team, are poised to enhance the quality of care provided, and prepared to drive excellence throughout all PTC substance use disorder treatment programs. “We are thrilled to welcome Dr. Dennis and Dr. Kottraba to our team,” said Michael Lawler, CEO of Pinnacle Treatment Centers.…